Kiniksa Pharmaceuticals International (KNSA) News Today $33.07 +0.12 (+0.36%) Closing price 08/5/2025 04:00 PM EasternExtended Trading$33.24 +0.17 (+0.53%) As of 08/5/2025 07:41 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock KNSA Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period Kiniksa Pharmaceuticals International (NASDAQ:KNSA) Reaches New 52-Week High - What's Next?August 5 at 10:47 AM | marketbeat.comBIT Capital GmbH Invests $264,000 in Kiniksa Pharmaceuticals International, plc (NASDAQ:KNSA)August 4 at 8:32 AM | marketbeat.comKiniksa Pharmaceuticals International (NASDAQ:KNSA) Raised to Strong-Buy at Wall Street ZenAugust 3 at 3:51 AM | marketbeat.comWedbush Has Optimistic Outlook of KNSA Q3 EarningsAugust 3 at 2:29 AM | americanbankingnews.comWedbush Research Analysts Lift Earnings Estimates for KNSAAugust 2, 2025 | marketbeat.comJust The Tonic: This Medical Stock, A Mutual Fund Darling, Tests Entry Amid 58% RunAugust 1, 2025 | investors.comVictory Capital Management Inc. Takes $1.18 Million Position in Kiniksa Pharmaceuticals International, plc (NASDAQ:KNSA)July 31, 2025 | marketbeat.comKiniksa Pharmaceuticals International (NASDAQ:KNSA) Given New $54.00 Price Target at Jefferies Financial GroupJuly 30, 2025 | marketbeat.comKiniksa Pharmaceuticals International (NASDAQ:KNSA) Hits New 12-Month High Following Better-Than-Expected EarningsJuly 30, 2025 | marketbeat.comKiniksa Pharmaceuticals International (NASDAQ:KNSA) Announces Quarterly Earnings ResultsJuly 30, 2025 | marketbeat.comKiniksa raises ARCALYST 2025 revenue guidance to $625M-$640M as patient penetration risesJuly 30, 2025 | msn.comKiniksa Pharmaceuticals International (NASDAQ:KNSA) Reaches New 1-Year High Following Earnings BeatJuly 30, 2025 | americanbankingnews.comKiniksa Pharmaceuticals International, Plc: Kiniksa Pharmaceuticals Reports Second Quarter 2025 Financial Results and Recent Portfolio ExecutionJuly 29, 2025 | finanznachrichten.deKiniksa Pharmaceuticals International, plc 2025 Q2 - Results - Earnings Call PresentationJuly 29, 2025 | seekingalpha.comKiniksa Pharmaceuticals International, plc (KNSA) Q2 2025 Earnings Call TranscriptJuly 29, 2025 | seekingalpha.comEarnings To Watch: Kiniksa Pharmaceuticals International PLC (KNSA) Reports Q2 2025 ResultJuly 29, 2025 | finance.yahoo.comKiniksa Pharmaceuticals Reports Second Quarter 2025 Financial Results and Recent Portfolio ExecutionJuly 29, 2025 | globenewswire.comEarnings Preview: Kiniksa PharmaceuticalsJuly 28, 2025 | benzinga.comKiniksa Pharmaceuticals International, plc Q2 2025 Earnings PreviewJuly 28, 2025 | msn.comKiniksa Pharmaceuticals International, plc (NASDAQ:KNSA) Given Average Recommendation of "Buy" by BrokeragesJuly 27, 2025 | americanbankingnews.comKiniksa Pharmaceuticals International, plc (NASDAQ:KNSA) Given Average Rating of "Buy" by AnalystsJuly 27, 2025 | marketbeat.comCwm LLC Has $491,000 Holdings in Kiniksa Pharmaceuticals International, plc (NASDAQ:KNSA)July 25, 2025 | marketbeat.comKiniksa Pharmaceuticals to Report Second Quarter 2025 Financial Results on July 29, 2025July 24, 2025 | globenewswire.comCerity Partners LLC Boosts Stock Holdings in Kiniksa Pharmaceuticals International, plc (NASDAQ:KNSA)July 24, 2025 | marketbeat.comWedbush Reaffirms Outperform Rating for Kiniksa Pharmaceuticals International (NASDAQ:KNSA)July 21, 2025 | marketbeat.comKNSA Company Profile & Executives - Kiniksa Pharmaceuticals ...July 20, 2025 | wsj.comInsider Selling: Kiniksa Pharmaceuticals International, plc (NASDAQ:KNSA) COO Sells 18,900 Shares of StockJuly 17, 2025 | insidertrades.comKiniksa Pharmaceuticals International, plc (NASDAQ:KNSA) COO Eben Tessari Sells 18,900 SharesJuly 16, 2025 | marketbeat.comKiniksa Pharmaceuticals International PLC - Barron'sJuly 15, 2025 | barrons.comKiniksa Pharmaceuticals International (KNSA) Projected to Post Quarterly Earnings on TuesdayJuly 15, 2025 | marketbeat.comRice Hall James & Associates LLC Has $13.87 Million Stock Position in Kiniksa Pharmaceuticals International, plc (NASDAQ:KNSA)July 14, 2025 | marketbeat.comWells Fargo & Company Forecasts Strong Price Appreciation for Kiniksa Pharmaceuticals International (NASDAQ:KNSA) StockJuly 9, 2025 | marketbeat.comWealth Enhancement Advisory Services LLC Purchases New Shares in Kiniksa Pharmaceuticals International, plc (NASDAQ:KNSA)July 9, 2025 | marketbeat.comKiniksa Pharmaceuticals International (NASDAQ:KNSA) Upgraded at Wall Street ZenJuly 6, 2025 | marketbeat.comKiniksa Pharmaceuticals: A 7.9 Score and Room for GrowthJuly 2, 2025 | msn.comKiniksa Pharmaceuticals: A 7.9 Score and Room for GrowthJuly 2, 2025 | msn.comPeregrine Capital Management LLC Has $6.87 Million Stock Position in Kiniksa Pharmaceuticals International, plc (NASDAQ:KNSA)July 1, 2025 | marketbeat.comKiniksa Pharmaceuticals International (NASDAQ:KNSA) Lowered to "Hold" Rating by Wall Street ZenJune 28, 2025 | marketbeat.comAMI Asset Management Corp Acquires 26,010 Shares of Kiniksa Pharmaceuticals International, plc (NASDAQ:KNSA)June 26, 2025 | marketbeat.comKiniksa Pharmaceuticals International PLC - KNSA | Barron'sJune 24, 2025 | barrons.comKiniksa pharma COO Tessari sells $489k in sharesJune 19, 2025 | investing.comKiniksa pharma COO Tessari sells $489k in sharesJune 19, 2025 | investing.comEben Tessari Sells 17,300 Shares of Kiniksa Pharmaceuticals International, plc (NASDAQ:KNSA) StockJune 19, 2025 | insidertrades.comKiniksa Pharmaceuticals International, plc (NASDAQ:KNSA) Shares Bought by GAMMA Investing LLCJune 19, 2025 | marketbeat.comInsider Selling: Kiniksa Pharmaceuticals International, plc (NASDAQ:KNSA) COO Sells 17,300 Shares of StockJune 18, 2025 | marketbeat.comKiniksa Pharmaceuticals: Arcalyst Performs, KPL-387 Advancing FastJune 16, 2025 | seekingalpha.comKiniksa Pharmaceuticals (NASDAQ:KNSA) Upgraded at Wall Street ZenJune 14, 2025 | marketbeat.comKiniksa Pharmaceuticals (NASDAQ:KNSA) Shares Down 5.4% on Insider SellingJune 12, 2025 | marketbeat.comBarry D. Quart Sells 6,900 Shares of Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA) StockJune 12, 2025 | insidertrades.comBarry D. Quart Sells 6,900 Shares of Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA) StockJune 11, 2025 | marketbeat.com Get Kiniksa Pharmaceuticals International News Delivered to You Automatically Sign up to receive the latest news and ratings for KNSA and its competitors with MarketBeat's FREE daily newsletter. Email Address KNSA Media Mentions By Week KNSA Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. KNSA News Sentiment▼0.650.46▲Average Medical News Sentiment KNSA News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. KNSA Articles This Week▼155▲KNSA Articles Average Week Get Kiniksa Pharmaceuticals International News Delivered to You Automatically Sign up to receive the latest news and ratings for KNSA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Regencell Bioscience News Elanco Animal Health News Revolution Medicines News Grifols News TG Therapeutics News Nuvalent News CRISPR Therapeutics News Rhythm Pharmaceuticals News Lantheus News Axsome Therapeutics News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:KNSA) was last updated on 8/6/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored[Shocking New Report] U.S. Dollar To Crash?The "Death Spiral" Threatening Your Savings But this time, it's not just Dalio ringing the alarm bells…Goldco Precious Metals | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredOne stock to replace NvidiaInvesting Legend Hints the End May be Near for These 3 Iconic Stocks One company to replace Amazon… another...InvestorPlace | Sponsored[Warning] Buffett Indicator hits new All-Time-HighWarren Buffett has leaned on one key indicator for decades—and it just hit an all-time high. That’s not bullis...Golden Portfolio | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredMarket Crash Warning: How to Protect Your Wealth Before August 12thChina tariffs hit August 12—and experts warn a market meltdown may follow. A free guide from American Alter...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Kiniksa Pharmaceuticals International, plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Kiniksa Pharmaceuticals International With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free KNSA Stock Alerts